11/30
12:41 am
ivvd
A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development [Yahoo! Finance]
Low
Report
A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development [Yahoo! Finance]
11/27
02:49 pm
ivvd
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
06:43 am
ivvd
Invivyd (NASDAQ:IVVD) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
Low
Report
Invivyd (NASDAQ:IVVD) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
11/25
08:07 am
ivvd
Invivyd (NASDAQ:IVVD) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Medium
Report
Invivyd (NASDAQ:IVVD) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
11/25
08:01 am
ivvd
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/25
07:01 am
ivvd
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
Medium
Report
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
11/24
07:01 am
ivvd
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
Medium
Report
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
11/19
02:48 am
ivvd
Invivyd: Why I'm Selling The CDTX Read-Through Rally [Seeking Alpha]
Low
Report
Invivyd: Why I'm Selling The CDTX Read-Through Rally [Seeking Alpha]
11/18
03:51 pm
ivvd
Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination [Seeking Alpha]
Low
Report
Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination [Seeking Alpha]
11/17
11:50 pm
ivvd
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Low
Report
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/17
10:40 pm
ivvd
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
Low
Report
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
11/17
04:41 pm
ivvd
Invivyd Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
Low
Report
Invivyd Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
11/17
04:01 pm
ivvd
Invivyd Announces Proposed Public Offering of Common Stock
Medium
Report
Invivyd Announces Proposed Public Offering of Common Stock
11/16
09:36 pm
ivvd
Invivyd (IVVD) Is Up 48.3% After Strong Q3 Financials and FDA Trial Clearance for VYD2311 – Has the Bull Case Changed? [Yahoo! Finance]
High
Report
Invivyd (IVVD) Is Up 48.3% After Strong Q3 Financials and FDA Trial Clearance for VYD2311 – Has the Bull Case Changed? [Yahoo! Finance]
11/15
10:33 am
ivvd
Invivyd (NASDAQ:IVVD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
High
Report
Invivyd (NASDAQ:IVVD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/15
05:41 am
ivvd
Invivyd (IVVD) Valuation in Focus After Strong Q3 Revenue Growth and Smaller Net Loss [Yahoo! Finance]
High
Report
Invivyd (IVVD) Valuation in Focus After Strong Q3 Revenue Growth and Smaller Net Loss [Yahoo! Finance]
11/8
12:52 pm
ivvd
What Catalysts Are Transforming the Invivyd Story for Investors? [Yahoo! Finance]
Low
Report
What Catalysts Are Transforming the Invivyd Story for Investors? [Yahoo! Finance]
11/6
07:01 am
ivvd
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Medium
Report
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
11/5
08:30 am
ivvd
Invivyd Inc (IVVD) Q3 2025 Earnings Report Preview: What to Expect [Yahoo! Finance]
Neutral
Report
Invivyd Inc (IVVD) Q3 2025 Earnings Report Preview: What to Expect [Yahoo! Finance]
11/3
04:01 pm
ivvd
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
High
Report
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
10/31
12:11 pm
ivvd
Invivyd (NASDAQ:IVVD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Invivyd (NASDAQ:IVVD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/28
07:01 am
ivvd
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Low
Report
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
10/17
05:44 am
ivvd
Invivyd (NASDAQ:IVVD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Invivyd (NASDAQ:IVVD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/9
06:31 am
ivvd
Invivyd (IVVD) Is Up 34.4% After FDA Clears Late-Stage COVID Antibody Program—What's Changed [Yahoo! Finance]
Medium
Report
Invivyd (IVVD) Is Up 34.4% After FDA Clears Late-Stage COVID Antibody Program—What's Changed [Yahoo! Finance]
10/6
02:05 pm
ivvd
Invivyd (NASDAQ:IVVD) had its price target raised by analysts at D. Boral Capital from $1.00 to $2.00. They now have a "buy" rating on the stock.
Low
Report
Invivyd (NASDAQ:IVVD) had its price target raised by analysts at D. Boral Capital from $1.00 to $2.00. They now have a "buy" rating on the stock.